Sjögren’s Syndrome News

Researchers appear to have identified novel serum proteins that may serve as biomarkers for salivary dysfunction in patients with primary Sjögren’s syndrome, according to recently presented study data.

Researchers from the Karolinska University Hospital in Stockholm recently presented data that showed men with primary Sjögren’s syndrome tended to have higher levels of autoantibodies and a greater number of extraglandular manifestations of disease than women.

Royal Philips announced the release of Lumify, a subscription-based smart device ultrasound solution for purchase by licensed U.S. health care providers and organizations.

SAN FRANCISCO — Levels of fatigue and depression, followed by anxiety and pain, were predictive of a reduction in overall quality of life, the ability to perform daily activities and the ability to take on life roles by patients with primary Sjögren’s syndrome, according to recently presented research.

Results from a systematic review of studies suggest there is inconclusive evidence about any association between silicone gel breast implants and long-term health outcomes.

SAN FRANCISCO — Leonard H. Calabrese, DO, of the Cleveland Clinic and Chief Medical Editor of Healio Rheumatology, reviews the importance of key studies on viruses, which were presented here at the American College of Rheumatology Annual Meeting.

The American College of Rheumatology Annual Meeting in San Francisco begins on Nov. 7, and Healio Rheumatology will cover the event and its many topics — ranging from rheumatoid arthritis to spondyloarthropathies, osteoarthritis, systemic lupus erythematosus, scleroderma, vasculitis, fibromyalgia, juvenile arthritis and much more— throughout the week.

Welcome to the Premier Issue of Healio Rheumatology, a print publication based on the most important news as measured by the online preferences of your colleagues. In this issue, you will find the most-read content from readers of Healio.com/Rheumatology, our online news site for rheumatology. We call this unique approach to issue content selection “Peer-Tested Content” and we believe the approach will provide you the best and most valuable content in your area of expertise.

Recently published data show patients with primary Sjögren’s syndrome who responded to treatment with Benlysta had lower levels of natural killer cells in both blood and saliva.